The renal sympathetic and renin-angiotensin response to lower body negative pressure in well-compensated cirrhosis Florence Wong*, Kenneth Sniderman‡,

Slides:

Advertisements

Similar presentations

Serum immunoglobulin a from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation Tuula Halttunen, Markku Mäki.

Advertisements

V.M. Campese, N. Mitra, D. Sandee Kidney International

It's time to bring the best and brightest back to gastroenterology!

Renin-angiotensin-aldosterone and potassium-aldosterone feedback loops

Native ace enzyme Angiotensin-converting enzyme (EC ), or "ACE" indirectly increases blood pressure by causing blood vessels to constrict. It does.

Renal Function Testing

Aleena Banerji, MD, Kimberly G. Blumenthal, MD, MSc, Kenneth H

Volume 82, Issue 1, Pages 7-8 (July 2012)

Viper venom for diabetic nephropathy

Frederic Rahbari-Oskoui, MD, MS American Journal of Kidney Diseases

Vasoconstrictor Therapy for the Hepatorenal Syndrome

Diagnosis of irritable bowel syndrome

Diagnosis of celiac sprue

Leptin, obesity, and liver disease

Natriuretic peptides and cardio-renal disease

Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications? William E. Whitehead, Olafur.

Volume 12, Issue 5, Pages (November 2010)

Psychiatric disorders among veterans with hepatitis C infection

Membranous nephropathy: When and how to treat

Viper venom for diabetic nephropathy

Hepatitis B infection in heart transplant recipients

Rifaximin Improves Systemic Hemodynamics and Renal Function in Patients With Alcohol-Related Cirrhosis and Ascites Georgios N. Kalambokis, Athanasia.

In This Issue Cell Volume 158, Issue 5, (August 2014)

Preventing and Treating Acute Kidney Injury Among Hospitalized Patients with Cirrhosis and Ascites: A Narrative Review Elliot B. Tapper, MD, Alan Bonder,

Volume 31, Issue 6, (December 1999)

Renoprotective effects of vitamin D analogs

Volume 62, Issue 3, Pages (March 2015)

Hepatorenal syndrome in cirrhosis: Pathogenesis and treatment

Volume 20, Issue 8, Pages v-vi (August 2012)

Incidence of Statin Hepatotoxicity in Patients With Hepatitis C

Volume 120, Issue 4, Pages (March 2001)

Volume 63, Issue 3, Pages (March 2003)

Quiz Page July 2007 American Journal of Kidney Diseases

Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016 Murray Epstein, MD, Daniel A. Duprez,

Autosomal dominant distal renal tubular acidosis and the AE1 gene

Laurence J. Egan Clinical Gastroenterology and Hepatology

Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency Fiona E. Mackie, Timothy W. Meyer,

Meeting AHA/ACC secondary prevention goals in a vascular surgery practice: An opportunity we cannot afford to miss Daniel Kinikini, MD, Mark R. Sarfati,

Biff F. Palmer, MD American Journal of Kidney Diseases

Volume 63, Issue 2, Pages (February 2003)

Volume 86, Issue 5, Pages (November 2014)

AGA technical review on nonalcoholic fatty liver disease

Volume 86, Issue 3, Pages (September 2014)

Psychiatric disorders among veterans with hepatitis C infection

Volume 361, Issue 9352, Pages (January 2003)

David M. Charytan, John P. Forman Kidney International

Special deLIVERy: podocyte injury promotes renal angiotensin II generation from liver- derived angiotensinogen David I. Ortiz-Melo, Robert F. Spurney

Volume 114, Issue 2, Pages (February 1998)

Angiotensin converting enzyme inhibitor captopril modifies conditioned place preference induced by morphine and morphine withdrawal signs in rats Hojjatallah.

The future of renoprotection: Frustration and promises

Chronic Diarrhea Clinical Gastroenterology and Hepatology

Table of Contents Nurse Leader Volume 16, Issue 4, (August 2018)

AGA technical review on osteoporosis in gastrointestinal diseases

Quiz Page August 2007 American Journal of Kidney Diseases

Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats Quaisar Ali,

Volume 42, Issue 2, Pages (August 1962)

The North American Study for the Treatment of Refractory Ascites

Volume 38, Issue 1, Pages (January 2003)

Volume 118, Issue 3, Pages (March 2000)

Volume 68, Issue 2, Pages (August 2005)

Volume 68, Issue 5, Pages (November 2005)

Volume 57, Issue 3, Pages (March 2000)

Volume 65, Issue 4, Pages (April 2004)

Effect of angiotensin-converting enzyme inhibitor on renal function in ovarian hyperstimulation syndrome in the rabbit Maria Jose G Teruel, Ph.D., Luis.

Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: Pathophysiology and indications

Volume 66, Issue 4, Pages (October 2004)

Angiotensin I-Converting Enzyme

Natriuretic peptides and cardio-renal disease

Hepatic oxygen supplementation as therapy in cirrhotic liver disease

Surviving Heart Failure: Robert L. Frye Lecture

Presentation transcript:

The renal sympathetic and renin-angiotensin response to lower body negative pressure in well-compensated cirrhosis Florence Wong*, Kenneth Sniderman‡, Laurence Blendis*,§ Gastroenterology Volume 115, Issue 2, Pages 397-405 (August 1998) DOI: 10.1016/S0016-5085(98)70206-9 Copyright © 1998 American Gastroenterological Association Terms and Conditions

Fig. 1 Schematic representation of the effects of LBNP on the SNS and the renin-angiotensin system. ACE, angiotensin-converting enzyme; Ang, angiotensin. Gastroenterology 1998 115, 397-405DOI: (10.1016/S0016-5085(98)70206-9) Copyright © 1998 American Gastroenterological Association Terms and Conditions

Fig. 2 CVP measurements with LBNP in both the controls (●) and cirrhotics (▴). #P < 0.05, controls vs. cirrhotics. *P < 0.05 compared with baseline. Gastroenterology 1998 115, 397-405DOI: (10.1016/S0016-5085(98)70206-9) Copyright © 1998 American Gastroenterological Association Terms and Conditions

Fig. 3 Urinary sodium excretion with LBNP in both controls (●) and cirrhotics (▴). #P < 0.05, controls vs. cirrhotics. *P < 0.05 compared with baseline. Gastroenterology 1998 115, 397-405DOI: (10.1016/S0016-5085(98)70206-9) Copyright © 1998 American Gastroenterological Association Terms and Conditions

Fig. 4 (A) Renal renin secretion rate. (B) Renal Ang II secretion rate with LBNP in both controls (●) and cirrhotics (▴). #P < 0.05, controls vs. cirrhotics. *P < 0.05 compared with baseline. Gastroenterology 1998 115, 397-405DOI: (10.1016/S0016-5085(98)70206-9) Copyright © 1998 American Gastroenterological Association Terms and Conditions